‹ All Posts
DEEPAK PAL

9th Sep · SEBI-Registered Analyst

Daily Chart Analysis on
AUROPHARMA

AUROPHARMA
Aurobindo Pharma Ltd. (AUROPHARMA) –
AUROPHARMA
Stock Analysis Technical View (Daily Chart) •Price Action: Current price is around ₹1043.90.
AUROPHARMA
Stock has been in a downtrend since mid-July, but currently attempting to form a short-term base near ₹1020–1040. •Moving Averages: Price is trading below 20, 50, 100 & 200 DMA, indicating the broader trend remains weak. •Parabolic SAR: Dots are still above the candles, signaling ongoing bearish pressure. •MACD: Negative, but histogram shows signs of narrowing, suggesting selling pressure may be reducing. •RSI (14): At 43, indicating stock is in neutral-to-oversold zone (not yet overbought). Conclusion: Immediate resistance lies near ₹1065–1080. If crossed,
AUROPHARMA
stock can see recovery towards ₹1110–1130. Support is placed at ₹1010–1020. Sustaining below ₹1010 may extend weakness to ₹980. Upcoming Events & Impact •USFDA Plant Inspections: Any clearance will be a strong positive trigger for the
AUROPHARMA
stock. •Q2 FY26 Results (Nov 2025): Key factors will be US sales growth, margin improvement, and R&D spend. •Global Pharma Demand: Increased demand for specialty & oncology products could support long-term growth.
AUROPHARMA
AUROPHARMA
AUROPHARMA
AUROPHARMA

#TechnicalViews#TrendingSectors#HiddenGems#EquityResearch#WatchOutFor
Daily Chart Analysis on AUROPHARMA as on 09092025.pdf
560 likes·54 comments